Gen Z Perceives Atopic Dermatitis to Be More Severe
By Lori Solomon HealthDay Reporter
TUESDAY, July 30, 2024 -- Generation Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published online July 25 in the International Journal of Dermatology.
Clara Ureña-Paniego, from the University of Granada in Spain, and colleagues compared the clinical severity and subjective impact of atopic dermatitis between Gen Z patients (born between 1993 and 2001) and millennials (born between 1978 and 1992). The analysis included 73 patients with moderate-to-severe atopic dermatitis.
The researchers found that patients belonging to Gen Z exhibited a lower severity of atopic dermatitis versus millennials (Eczema Area and Severity Index: 9.75 versus 16.63). However, the two generations were similar with respect to their perception of disease severity (SCORing Atopic Dermatitis: 43.54 versus 32.98; Patient-Oriented Eczema Measure: 13.21 versus 15.48).
"Gen Z presents a higher subjective perception of severity than millennials. Understanding these generational disparities contributes to creating more effective treatment strategies and provides a more targeted approach to care that addresses each generational group's unique needs and expectations," the authors write. "This approach could include enhanced patient education on treatment risks and expectations, regular follow-up visits for timely treatment adjustment, integration of nonpharmacological therapies like stress management and use of emollients, and inclusion of mental health professionals in the care team."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
MONDAY, June 9, 2025 -- Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study...
AI Three-Item Severity Score Can ID Eczema From Patient-Uploaded Images
FRIDAY, May 23, 2025 -- An artificial intelligence (AI) Three-Item Severity (TIS) score can identify eczema-affected areas and severity scores from user-uploaded images, according...
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 -- In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.